Materials & Resources » Chemicals | Dynasil Corp.

Dynasil Corp. of America | Balance Sheet

Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,436.80
3,842.00
1,295.00
2,607.00
2,415.00
2,327
Total Accounts Receivable
5,194.60
4,475.00
4,900.00
4,710.00
4,724.00
5,284
Inventories
3,140.20
2,954.00
3,066.00
3,726.00
4,326.00
4,106
Other Current Assets
1,291.90
919.00
1,167.00
1,078.00
973.00
664
Total Current Assets
12,063.70
12,190.00
10,428.00
12,121.00
12,438.00
12,381
Net Property, Plant & Equipment
4,773.80
6,518.00
6,662.00
7,223.00
7,032.00
8,098
Intangible Assets
9,725.60
7,630.00
7,356.00
6,965.00
6,927.00
6,655
Other Assets
114.20
39.00
70.00
60.00
58.00
65
Total Assets
26,677.20
26,377.00
24,516.00
27,102.00
30,047.00
32,732
ST Debt & Current Portion LT Debt
9,943.40
3,896.00
3,776.00
5,667.00
2,098.00
Accounts Payable
2,056.30
1,602.00
1,886.00
1,627.00
2,380.00
Other Current Liabilities
3,362.60
2,606.00
2,759.00
3,193.00
2,796.00
Total Current Liabilities
15,362.30
8,104.00
8,421.00
10,487.00
7,274.00
Long-Term Debt
232.20
3,377.00
1,333.00
909.00
1,126.00
Provision for Risks & Charges
250.00
318.00
-
-
-
Deferred Taxes
186.90
264.00
284.00
263.00
2,408.00
Other Liabilities
-
-
50.00
43.00
38.00
Total Liabilities
16,031.30
12,063.00
10,088.00
12,435.00
9,622.00
Common Equity (Total)
10,645.90
14,383.00
14,616.00
14,973.00
18,971.00
Total Shareholders' Equity
10,645.90
14,383.00
14,616.00
14,973.00
18,971.00
Total Equity
10,645.90
14,314.00
14,428.00
14,667.00
20,425.00
Liabilities & Shareholders' Equity
26,677.20
26,377.00
24,516.00
27,102.00
30,047.00
Accumulated Minority Interest
-
69.00
188.00
306.00
1,454.00

About Dynasil

View Profile
Address
313 Washington Street
Newton Massachusetts 02458
United States
Employees -
Website http://www.dynasil.com
Updated 07/08/2019
Dynasil Corp. of America develops, manufactures and markets detection, sensing, and analysis technology products for the homeland security, medical and industrial markets. It operates through the following segments: Contract Research, Optics, and Biomedical. The Contract Research segment consists of the Radiation Monitoring Devices, Inc. which performs research and development activities for government agencies.